ES2095874T3 - Vacuna acelular. - Google Patents
Vacuna acelular.Info
- Publication number
- ES2095874T3 ES2095874T3 ES90907222T ES90907222T ES2095874T3 ES 2095874 T3 ES2095874 T3 ES 2095874T3 ES 90907222 T ES90907222 T ES 90907222T ES 90907222 T ES90907222 T ES 90907222T ES 2095874 T3 ES2095874 T3 ES 2095874T3
- Authority
- ES
- Spain
- Prior art keywords
- vaccine
- cellular vaccine
- antigens
- pertussis
- kda
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Liquid Crystal Substances (AREA)
- Peptides Or Proteins (AREA)
Abstract
SE PRESENTA UNA VACUNA ACELULAR QUE CUANDO SE UTILIZA PROPORCIONA UNA PROTECCION CONTRA INFECCIONES DE LA BORDETELLA PERTUSSIS. LA VACUNA SE BASA EN LA COMBINACION SINERGISTICA DE DOS ANTIGENOS DE LA B. PERTUSSIS, EL KDA 69 Y LOS ANTIGENOS DE HEMAGLUTININA FILAMENTOSOS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898910570A GB8910570D0 (en) | 1989-05-08 | 1989-05-08 | Acellular vaccine |
GB8910570 | 1989-05-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2095874T3 true ES2095874T3 (es) | 1997-03-01 |
ES2095874T5 ES2095874T5 (es) | 2008-11-01 |
Family
ID=10656410
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90907222T Expired - Lifetime ES2095874T5 (es) | 1989-05-08 | 1990-04-26 | Vacuna acelular. |
ES96112324T Expired - Lifetime ES2230555T3 (es) | 1989-05-08 | 1990-04-26 | Vacuna acelular. |
ES04018329T Expired - Lifetime ES2322352T3 (es) | 1989-05-08 | 1990-04-26 | Procedimiento de produccion de una vacuna acelular que contiene antigenos de bordetella pertussis. |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96112324T Expired - Lifetime ES2230555T3 (es) | 1989-05-08 | 1990-04-26 | Vacuna acelular. |
ES04018329T Expired - Lifetime ES2322352T3 (es) | 1989-05-08 | 1990-04-26 | Procedimiento de produccion de una vacuna acelular que contiene antigenos de bordetella pertussis. |
Country Status (12)
Country | Link |
---|---|
US (1) | US7479283B1 (es) |
EP (3) | EP1666057B1 (es) |
JP (2) | JP3281369B2 (es) |
AT (3) | ATE422900T1 (es) |
DE (14) | DE69034264D1 (es) |
DK (3) | DK1666057T3 (es) |
ES (3) | ES2095874T5 (es) |
FR (1) | FR09C0033I1 (es) |
GB (1) | GB8910570D0 (es) |
LU (15) | LU90204I2 (es) |
NL (13) | NL980007I1 (es) |
WO (1) | WO1990013313A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8412207D0 (en) * | 1984-05-12 | 1984-06-20 | Wellcome Found | Antigenic preparations |
GB8910570D0 (en) | 1989-05-08 | 1989-06-21 | Wellcome Found | Acellular vaccine |
EP0484621A3 (en) * | 1990-07-11 | 1992-08-26 | American Cyanamid Company | Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens |
GB9021004D0 (en) * | 1990-09-27 | 1990-11-07 | Wellcome Found | Acellular vaccines |
GB9209118D0 (en) * | 1992-04-28 | 1992-06-10 | Sb 120 Amsterdam Bv | Vaccine compositions |
FR2754543B1 (fr) * | 1996-10-11 | 1998-12-31 | Pasteur Institut | Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires |
US7022522B2 (en) | 1998-11-13 | 2006-04-04 | Limin Guan | Macroporous polymer scaffold containing calcium phosphate particles |
US8574596B2 (en) * | 2003-10-02 | 2013-11-05 | Glaxosmithkline Biologicals, S.A. | Pertussis antigens and use thereof in vaccination |
US8877201B2 (en) * | 2007-10-25 | 2014-11-04 | Wake Forest University Health Sciences | Bordetella outer-membrane protein antigens and methods of making and using the same |
EP2250144A4 (en) | 2008-03-07 | 2014-06-04 | Arkema Inc | FORMULATED AND STABLE SYSTEMS CONTAINING CHLORO-3,3,3-TRIFLUOROPROPENE |
GB201105981D0 (en) | 2011-04-08 | 2011-05-18 | Glaxosmithkline Biolog Sa | Novel process |
BR112015021523A8 (pt) | 2013-03-08 | 2021-06-29 | Crucell Holland Bv | composição de uma vacina contra a tosse convulsa acelular, e, usos da composição e de antígenos da bordetella pertussis |
CA2923129C (en) | 2013-09-08 | 2020-06-09 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
WO2016132294A1 (en) | 2015-02-19 | 2016-08-25 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2047886A1 (en) | 1969-06-30 | 1971-03-19 | Merieux Inst | Non-toxic anti-whooping cough vaccine |
DE3176347D1 (en) | 1980-06-27 | 1987-09-17 | Ciba Geigy Ag | Synergistic agents and method for the selective control of weeds, particularly in cereals and soybeans |
JPS5750925A (en) | 1980-09-12 | 1982-03-25 | Takeda Chem Ind Ltd | Preparation of pertussis toxoid |
JPS58222032A (ja) | 1982-06-18 | 1983-12-23 | Teijin Ltd | 百日咳毒素のサブユニツト蛋白 |
GB8412207D0 (en) * | 1984-05-12 | 1984-06-20 | Wellcome Found | Antigenic preparations |
US5237052A (en) * | 1984-05-12 | 1993-08-17 | Burroughs Wellcome Company | Antigenic preparations and isolation of such preparations |
JPS6176422A (ja) * | 1984-09-22 | 1986-04-18 | Chemo Sero Therapeut Res Inst | 百日ぜきコンポ−ネントワクチンおよび百日ぜき・ジフテリア・破傷風混合ワクチンの製造方法 |
FR2590483B1 (fr) | 1985-11-22 | 1988-12-09 | Pasteur Institut | Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant |
GB8601279D0 (en) * | 1986-01-20 | 1986-02-26 | Public Health Lab Service | Purification of pertussis antigens |
EP0267498B1 (de) * | 1986-11-11 | 1993-01-27 | Siemens Aktiengesellschaft | Flusskompensierter Stromwandler |
FR2606789B1 (fr) | 1986-11-17 | 1991-05-31 | Pasteur Institut | Preparations d'adenylate cyclase purifiees, procede d'obtention de ces preparations et leurs applications biologiques |
EP0267998A1 (en) * | 1986-11-17 | 1988-05-25 | Institut Pasteur | Means for protecting against bordetella infections and toxic processes |
US5358868A (en) * | 1987-11-24 | 1994-10-25 | Connaught Laboratories Limited | Genetic detoxification of pertussis toxin |
GB8807860D0 (en) | 1988-04-05 | 1988-05-05 | Connaught Lab | Pertussis vaccine |
US5101014A (en) * | 1989-02-10 | 1992-03-31 | United States Of America | Process for the purification of a 69,000 da outer membrane protein of Bordetella pertussis |
US5162223A (en) * | 1989-02-17 | 1992-11-10 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Resources | Hybridomas and resulting monoclonal antibodies directed against antigens of Bordetella pertussis |
GB8910570D0 (en) | 1989-05-08 | 1989-06-21 | Wellcome Found | Acellular vaccine |
US5276142A (en) | 1989-12-11 | 1994-01-04 | American Cyanamid Company | Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis |
GB9007416D0 (en) | 1990-04-02 | 1990-05-30 | Wellcome Found | Expression of heterologous protein in yeast |
GB9007657D0 (en) | 1990-04-04 | 1990-05-30 | Connaught Lab | Purification of a pertussis outer membrane protein(omp69) |
IT1248735B (it) | 1990-06-21 | 1995-01-26 | Sclavo Spa | Vaccini acellulari contro la pertosse |
EP0484621A3 (en) | 1990-07-11 | 1992-08-26 | American Cyanamid Company | Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens |
AU2352595A (en) | 1994-04-28 | 1995-11-29 | Takeda Chemical Industries Ltd. | Method of separating protective components of bordetella pertussis |
US5972225A (en) * | 1996-05-07 | 1999-10-26 | Cook Imaging Corporation | Process for remediating endotoxin-contaminated bulk non-ionic contrast media |
-
1989
- 1989-05-08 GB GB898910570A patent/GB8910570D0/en active Pending
-
1990
- 1990-04-26 AT AT04018329T patent/ATE422900T1/de active
- 1990-04-26 AT AT96112324T patent/ATE276759T1/de active
- 1990-04-26 EP EP04018329A patent/EP1666057B1/en not_active Expired - Lifetime
- 1990-04-26 DE DE69034264T patent/DE69034264D1/de not_active Expired - Lifetime
- 1990-04-26 WO PCT/GB1990/000649 patent/WO1990013313A1/en active IP Right Grant
- 1990-04-26 DE DE200512000014 patent/DE122005000014I1/de active Pending
- 1990-04-26 ES ES90907222T patent/ES2095874T5/es not_active Expired - Lifetime
- 1990-04-26 DE DE200512000019 patent/DE122005000019I1/de active Pending
- 1990-04-26 DK DK04018329T patent/DK1666057T3/da active
- 1990-04-26 DK DK96112324T patent/DK0747058T3/da active
- 1990-04-26 DE DE200512000016 patent/DE122005000016I1/de active Pending
- 1990-04-26 ES ES96112324T patent/ES2230555T3/es not_active Expired - Lifetime
- 1990-04-26 EP EP90907222A patent/EP0471726B2/en not_active Expired - Lifetime
- 1990-04-26 DE DE122009000042C patent/DE122009000042I1/de active Pending
- 1990-04-26 AT AT90907222T patent/ATE147271T1/de active
- 1990-04-26 DE DE69034166T patent/DE69034166T2/de not_active Expired - Lifetime
- 1990-04-26 DE DE200512000018 patent/DE122005000018I1/de active Pending
- 1990-04-26 DE DE122009000041C patent/DE122009000041I1/de active Pending
- 1990-04-26 DE DE200512000017 patent/DE122005000017I1/de active Pending
- 1990-04-26 DE DE69029656T patent/DE69029656T3/de not_active Expired - Lifetime
- 1990-04-26 ES ES04018329T patent/ES2322352T3/es not_active Expired - Lifetime
- 1990-04-26 DE DE122009000043C patent/DE122009000043I1/de active Pending
- 1990-04-26 EP EP96112324A patent/EP0747058B1/en not_active Revoked
- 1990-04-26 DE DE200512000020 patent/DE122005000020I1/de active Pending
- 1990-04-26 JP JP50666890A patent/JP3281369B2/ja not_active Expired - Lifetime
- 1990-04-26 DK DK90907222T patent/DK0471726T4/da active
- 1990-04-26 DE DE122009000044C patent/DE122009000044I1/de active Pending
-
1995
- 1995-05-25 US US08/450,336 patent/US7479283B1/en active Active
-
1998
- 1998-01-27 NL NL980007C patent/NL980007I1/nl unknown
- 1998-01-28 LU LU90204C patent/LU90204I2/fr unknown
-
2002
- 2002-01-09 JP JP2002002530A patent/JP2002226397A/ja active Pending
-
2004
- 2004-10-28 DE DE200512000015 patent/DE122005000015I1/de active Pending
-
2005
- 2005-03-22 LU LU91151C patent/LU91151I2/fr unknown
- 2005-03-22 LU LU91155C patent/LU91155I2/fr unknown
- 2005-03-22 NL NL300186C patent/NL300186I1/nl unknown
- 2005-03-22 LU LU91152C patent/LU91152I2/fr unknown
- 2005-03-22 LU LU91150C patent/LU91150I2/fr unknown
- 2005-03-22 NL NL300183C patent/NL300183I1/nl unknown
- 2005-03-22 LU LU91149C patent/LU91149I2/fr unknown
- 2005-03-22 LU LU91154C patent/LU91154I2/fr unknown
- 2005-03-22 NL NL300184C patent/NL300184I1/nl unknown
- 2005-03-22 NL NL300187C patent/NL300187I1/nl unknown
- 2005-03-22 NL NL300185C patent/NL300185I1/nl unknown
- 2005-03-22 NL NL300189C patent/NL300189I1/nl unknown
- 2005-03-22 LU LU91153C patent/LU91153I2/fr unknown
- 2005-03-22 NL NL300188C patent/NL300188I1/nl unknown
-
2009
- 2009-08-11 NL NL300400C patent/NL300400I1/nl unknown
- 2009-08-11 NL NL300401C patent/NL300401I1/nl unknown
- 2009-08-11 NL NL300402C patent/NL300402I1/nl unknown
- 2009-08-11 NL NL300403C patent/NL300403I1/nl unknown
- 2009-08-11 NL NL300404C patent/NL300404I1/nl unknown
- 2009-08-12 LU LU91591C patent/LU91591I2/fr unknown
- 2009-08-12 LU LU91592C patent/LU91592I2/fr unknown
- 2009-08-12 LU LU91593C patent/LU91593I2/fr unknown
- 2009-08-12 LU LU91595C patent/LU91595I2/fr unknown
- 2009-08-12 LU LU91597C patent/LU91597I2/fr unknown
- 2009-08-12 LU LU91594C patent/LU91594I2/fr unknown
- 2009-08-12 LU LU91596C patent/LU91596I2/fr unknown
- 2009-08-13 FR FR09C0033C patent/FR09C0033I1/fr active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL300184I1 (nl) | Acellulair vaccin. | |
ATE179614T1 (de) | Herpes simplex virus vp16 impfstoffe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 471726 Country of ref document: ES |